Oxidative stress in the pathogenesis of keratoconus and Fuchs endothelial corneal dystrophy

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 19294-19308

  Wojcik, Katarzyna A ^a   Kaminska, Anna ^b   Blasiak, Janusz ^a   Szaflik, Jerzy ^b   Szaflik, Jacek P ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antioxidants; Free radicals; Fuchs endothelial corneal dystrophy; Keratoconus; Oxidative stress

Indexed keywords

ALDEHYDE DEHYDROGENASE; COLLAGEN TYPE 4; COLLAGEN TYPE 8; GLUTATHIONE TRANSFERASE; METALLOTHIONEIN III; MITOCHONDRIAL DNA; PEROXIREDOXIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE;

ALDH3 GENE; BIOACCUMULATION; CELL DEATH; CELL PROLIFERATION; COL4A3 GENE; COL4A4 GENE; COL8A2 GENE; CONGENITAL CORNEA DYSTROPHY; DISEASE COURSE; DNA DAMAGE; ENZYME ACTIVITY; GENE; GENE MUTATION; HUMAN; KERATOCONUS; MT3 GENE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; SLC4A11 GENE; SOD1 GENE; TXNRD1 GENE;

DNA DAMAGE; DNA, MITOCHONDRIAL; FUCHS' ENDOTHELIAL DYSTROPHY; HUMANS; KERATOCONUS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84884564440     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140919294     Document Type: Review

References (78)

1. Choi, S.I.; Dadakhujaev, S.; Ryu, H.; Im Kim, T.; Kim, E.K. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J. Pineal Res. 2011, 51, 94-103.
2. Greinert, R.; Volkmer, B.; Henning, S.; Breitbart, E.W.; Greulich, K.O.; Cardoso, M.C.; Rapp, A. UVA-induced DNA double-strand breaks result from the repair of clustered oxidative DNA damages. Nucleic Acids Res. 2012, 40, 10263-10273.
3. Cai, C.X.; Birk, D.E.; Linsenmayer, T.F. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol. Biol. Cell. 1998, 9, 1037-1051.
4. Chen, Y.; Mehta, G.; Vasiliou, V. Antioxidant defenses in the ocular surface. Ocul. Surf. 2009, 7, 176-185.
5. Chai, D.; Gaster, R.N.; Roizenblatt, R.; Juhasz, T.; Brown, D.J.; Jester, J.V. Quantitative assessment of UVA-riboflavin corneal cross-linking using nonlinear optical microscopy. Invest. Ophthalmol. Vis. Sci. 2011, 52, 4231-4238.
6. Dröge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47-95.
7. Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239-247.
8. Birben, E.; Sahiner, U.M.; Sackesen, C.; Erzurum, S.; Kalayci, O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012, 5, 9-19.
9. Kryston, T.B.; Georgiev, A.B.; Pissis, P.; Georgakilas, A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res. 2011, 711, 193-201.
10. Valko, M.; Rhodes, C.J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160, 1-40.
11. Kenney, M.C.; Chwa, M.; Atilano, S.R.; Tran, A.; Carballo, M.; Saghizadeh, M.; Vasiliou, V.; Adachi, W.; Brown, D.J. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: Evidence that oxidative stress plays a role in this disorder. Invest. Ophthalmol. Vis. Sci. 2005, 46, 823-832.
12. Chwa, M.; Atilano, S.R.; Hertzog, D.; Zheng, H.; Langberg, J.; Kim, D.W.; Kenney, M.C. Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2008, 49, 4361-4369.
13. Jurkunas, U.V.; Bitar, M.S.; Funaki, T.; Azizi, B. Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. Am. J. Pathol. 2010, 177, 2278-2289.
14. Nakamura, S.; Shibuya, M.; Nakashima, H.; Hisamura, R.; Masuda, N.; Imagawa, T.; Uehara, M.; Tsubota, K. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest. Ophthalmol. Vis. Sci. 2007, 48, 1552-1558.
15. Marak, G.E.; de Kozak, Y.; Faure, J.P. Free radicals and antioxidants in the pathogenesis of eye diseases. Adv. Exp. Med. Biol. 1990, 264, 513-527.
16. Fang, Y.Z.; Yang, S.; Wu, G. Free radicals, antioxidants, and nutrition. Nutrition 2002, 18, 872-879.
17. Ishii, T.; Miyazawa, M.; Onouchi, H.; Yasuda, K.; Hartman, P.S.; Ishii, N. Model animals for the study of oxidative stress from complex II. Biochim. Biophys. Acta 2013, 1827, 588-597.
18. Trachootham, D.; Lu, W.; Ogasawara, M.A.; Nilsa, R.D.; Huang, P. Redox regulation of cell survival. Antioxid. Redox. Signal. 2008, 10, 1343-1374.
19. Kohen, R.; Nyska, A. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 2002, 30, 620-650.
20. Sheu, S.S.; Nauduri, D.; Anders, M.W. Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim. Biophys. Acta 2006, 1762, 256-265.
21. Sies, H. Oxidative stress: Oxidants and antioxidants. Exp. Physiol. 1997, 82, 291-295.
22. De Bonis, P.; Laborante, A.; Pizzicoli, C.; Stallone, R.; Barbano, R.; Longo, C.; Mazzilli, E.; Zelante, L.; Bisceglia, L. Mutational screening of VSX1, SPARC, SOD1, LOX, and TIMP3 in keratoconus. Mol. Vis. 2011, 17, 2482-2494.
23. Rabinowitz, Y.S. Keratoconus. Surv. Ophthalmol. 1998, 42, 297-319.
24. Romero-Jiménez, M.; Santodomingo-Rubido, J.; Wolffsohn, J.S. Keratoconus: A review. Cont. Lens Anterior Eye 2010, 33, 157-166.
25. Kim, W.J.; Rabinowitz, Y.S.; Meisler, D.M.; Wilson, S.E. Keratocyte apoptosis associated with keratoconus. Exp. Eye Res. 1999, 69, 475-481.
26. Ahmadi Hosseini, S.M.; Mohidin, N.; Abolbashari, F.; Mohd-Ali, B.; Santhirathelagan, C.T. Corneal thickness and volume in subclinical and clinical keratoconus. Int. Ophthalmol. 2013, 33, 139-145.
27. Sherwin, T.; Brookes, N.H. Morphological changes in keratoconus: Pathology or pathogenesis. Clin. Exp. Ophthalmol. 2004, 32, 211-217.
28. Burdon, K.P.; Vincent, A.L. Insights into keratoconus from a genetic perspective. Clin. Exp. Optom. 2013, 96, 146-154.
29. Edwards, M.; McGhee, C.N.; Dean, S. The genetics of keratoconus. Clin. Exp. Ophthalmol. 2001, 29, 345-351.
30. Kenney, M.C.; Brown, D.J. The cascade hypothesis of keratoconus. Cont. Lens Anterior Eye 2003, 26, 139-146.
31. Saee-Rad, S.; Hashemi, H.; Miraftab, M.; Noori-Daloii, M.R.; Chaleshtori, M.H.; Raoofian, R.; Jafari, F.; Greene, W.; Fakhraie, G.; Rezvan, F.; et al. Mutation analysis of VSX1 and SOD1 in Iranian patients with keratoconus. Mol. Vis. 2011, 17, 3128-3136.
32. Tanwar, M.; Kumar, M.; Nayak, B.; Pathak, D.; Sharma, N.; Titiyal, J.S.; Dada, R. VSX1 gene analysis in keratoconus. Mol. Vis. 2010, 16, 2395-2401.
33. Stabuc-Silih, M.; Strazisar, M.; Ravnik-Glavac, M.; Hawlina, M.; Glavac, D. Genetics and clinical characteristics of keratoconus. Acta Dermatovenerol. Alp. Panonica Adriat. 2010, 19, 3-10.
34. Stabuc-Silih, M.; Ravnik-Glavac, M.; Glavac, D.; Hawlina, M.; Strazisar, M. Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. Mol. Vis. 2009, 15, 2848-2860.
35. Hughes, A.E.; Bradley, D.T.; Campbell, M.; Lechner, J.; Dash, D.P.; Simpson, D.A.; Willoughby, C.E. Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am. J. Hum. Genet. 2011, 89, 628-633.
36. Chwa, M.; Atilano, S.R.; Reddy, V.; Jordan, N.; Kim, D.W.; Kenney, M.C. Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest. Ophthalmol. Vis. Sci. 2006, 47, 1902-1910.
37. Buddi, R.; Lin, B.; Atilano, S.R.; Zorapapel, N.C.; Kenney, M.C.; Brown, D.J. Evidence of oxidative stress in human corneal diseases. J. Histochem. Cytochem. 2002, 50, 341-351.
38. Squadrito, G.L.; Pryor, W.A. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic. Biol. Med. 1998, 25, 392-403.
39. Arnal, E.; Peris-Martínez, C.; Menezo, J.L.; Johnsen-Soriano, S.; Romero, F.J. Oxidative stress in keratoconus? Invest. Ophthalmol. Vis. Sci. 2011, 52, 8592-8597.
40. Uchida, K. Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 2000, 28, 1685-1696.
41. Kalra, J.; Mantha, S.V.; Kumar, P.; Prasad, K. Protective effects of lazaroids against oxygen-free radicals induced lysosomal damage. Mol. Cell. Biochem. 1994,136, 125-129.
42. Behndig, A.; Karlsson, K.; Johansson, B.O.; Brännström, T.; Marklund, S.L. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest. Ophthalmol. Vis. Sci. 2001, 42, 2293-2296.
43. Brown, D.J.; Lin, B.; Chwa, M.; Atilano, S.R.; Kim, D.W.; Kenney, M.C. Elements of the nitric oxide pathway can degrade TIMP-1 and increase gelatinase activity. Mol. Vis. 2004, 10, 281-288.
44. Olofsson, E.M.; Marklund, S.L.; Pedrosa-Domellöf, F.; Behndig, A. Interleukin-1alpha downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells. Mol. Vis. 2007, 13, 1285-1290.
45. Zelko, I.N.; Mariani, T.J.; Folz, R.J. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 2002, 33, 337-349.
46. Pappa, A.; Estey, T.; Manzer, R.; Brown, D.; Vasiliou, V. Human aldehyde dehydrogenase 3A1 (ALDH3A1): Biochemical characterization and immunohistochemical localization in the cornea. Biochem. J. 2003, 376, 615-23.
47. Owen, J.B.; Butterfield, D.A. Measurement of oxidized/reduced glutathione ratio. Methods Mol. Biol. 2010, 648, 269-277.
48. Collier, S.A. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases? Clin. Exp. Ophthalmol. 2001, 29, 340-344.
49. Guedez, L.; Stetler-Stevenson, W.G.; Wolff, L.; Wang, J.; Fukushima, P.; Mansoor, A.; Stetler-Stevenson, M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 1998, 102, 2002-2010.
50. Han, X.; Sun, Y.; Scott, S.; Bleich, D. Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes 2001, 50, 1047-1055.
51. Smith, V.A.; Hoh, H.B.; Littleton, M.; Easty, D.L. Over-expression of a gelatinase A activity in keratoconus. Eye 1995, 9, 429-433.
52. Zhou, L.; Sawaguchi, S.; Twining, S.S.; Sugar, J.; Feder, R.S.; Yue, B.Y. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest. Ophthalmol. Vis. Sci. 1998, 39, 1117-1124.
53. Atilano, S.R.; Coskun, P.; Chwa, M.; Jordan, N.; Reddy, V.; Le, K.; Wallace, D.C.; Kenney, M.C. Accumulation of mitochondrial DNA damage in keratoconus corneas. Invest. Ophthalmol. Vis. Sci. 2005, 46, 1256-1263.
54. De Grey, A.D.N.J. An Introduction to Mitochondria. History of the Mitochondrial Free Radical Theory of Aging, 1954-1995; In The Mitochondrial Free Radical Theory of Aging; R.G. Landes Company: Austin, TX, USA, 1999; pp. 20-30, 66-69.
55. Cui, H.; Kong, Y.; Zhang, H. Oxidative stress, mitochondrial dysfunction, and aging. J. Signal. Transduct. 2012, 2012, 646354.
56. Taylor, R.W.; Turnbull, D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6, 389-402.
57. Eghrari, A.O.; Gottsch, J.D. Fuchs' corneal dystrophy. Expert Rev. Ophthalmol. 2010, 5, 147-159.
58. Thalamuthu, A.; Khor, C.C.; Venkataraman, D.; Koh, L.W.; Tan, D.T.; Aung, T.; Mehta, J.S.; Vithana, E.N. Association of TCF4 gene polymorphisms with Fuchs' corneal dystrophy in the Chinese. Invest. Ophthalmol. Vis. Sci. 2011, 52, 5573-5578.
59. Klintworth, G.K. Corneal dystrophies. Orphanet J. Rare Dis. 2009, 4, 7.
60. Schrems-Hoesl, L.M.; Schrems, W.A.; Cruzat, A.; Shahatit, B.M.; Bayhan, H.A.; Jurkunas, U.V.; Hamrah P. Cellular and subbasal nerve alterations in early stage Fuchs' endothelial corneal dystrophy: An in vivo confocal microscopy study. Eye 2013, 27, 42-49.
61. Elhalis, H.; Azizi, B.; Jurkunas, U.V. Fuchs endothelial corneal dystrophy. Ocul. Surf. 2010, 8. 173-184.
62. Schmedt, T.; Silva, M.M.; Ziaei, A.; Jurkunas, U. Molecular bases of corneal endothelial dystrophies. Exp. Eye Res. 2012, 95, 24-34.
63. Peh, G.S.; Beuerman, R.W.; Colman, A.; Tan, D.T.; Mehta, J.S. Human corneal endothelial cell expansion for corneal endothelium transplantation: An overview. Transplantation 2011, 91, 811-819.
64. Bonanno, J.A. Identity and regulation of ion transport mechanisms in the corneal endothelium. Prog. Retin. Eye Res. 2003, 22, 69-94.
65. Iliff, B.W.; Riazuddin, S.A.; Gottsch, J.D. The genetics of Fuchs' corneal dystrophy. Expert Rev. Ophthalmol. 2012, 7, 363-375.
66. Hemadevi, B.; Srinivasan, M.; Arunkumar, J.; Prajna, N.V.; Sundaresan, P. Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India. BMC Ophthalmol. 2010, 10, 3.
67. Riazuddin, S.A.; Parker, D.S.; McGlumphy, E.J.; Oh, E.C.; Iliff, B.W.; Schmedt, T.; Jurkunas, U.; Schleif, R.; Katsanis, N.; Gottsch, J.D. Mutations in LOXHD1, a recessive-deafness locus, cause dominant late-onset Fuchs corneal dystrophy. Am. J. Hum. Genet. 2012, 90, 533-953.
68. Gottsch, J.D.; Bowers, A.L.; Margulies, E.H.; Seitzman, G.D.; Kim, S.W.; Saha, S.; Jun, A.S.; Stark, W.J.; Liu, S.H. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Invest. Ophthalmol. Vis. Sci. 2003, 44, 594-599.
69. Jurkunas, U.V.; Rawe, I.; Bitar, M.S.; Zhu, C.; Harris, D.L.; Colby, K.; Joyce, N.C. Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy. Invest. Ophthalmol. Vis. Sci. 2008, 49, 2956-2963.
70. Jolly, C.; Morimoto, R.I. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Inst. 2000, 92, 1564-1572.
71. Cadenas, C.; Franckenstein, D.; Schmidt, M.; Gehrmann, M.; Hermes, M.; Geppert, B.; Schormann, W.; Maccoux, L.J.; Schug, M.; Schumann, A.; et al. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res. 2010, 12, R44.
72. Nordberg, J.; Arnér, E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31, 1287-1312.
73. Carlson, B.A.; Yoo, M.H.; Tobe, R.; Mueller, C.; Naranjo-Suarez, S.; Hoffmann, V.J.; Gladyshev, V.N.; Hatfield, D.L. Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis 2012, 33, 1806-1813.
74. Lee, J.M.; Calkins, M.J.; Chan, K.; Kan, Y.W.; Johnson, J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 2003, 278, 12029-12038.
75. Ishii, T.; Itoh, K.; Takahashi, S.; Sato, H.; Yanagawa, T.; Katoh, Y.; Bannai, S.; Yamamoto, M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275, 16023-16029.
76. Czarny, P.; Kasprzak, E.; Wielgorski, M.; Udziela, M.; Markiewicz, B.; Blasiak, J.; Szaflik, J.; Szaflik, J.P. DNA damage and repair in Fuchs endothelial corneal dystrophy. Mol. Biol. Rep. 2013, 40, 2977-2983.
77. Gredilla, R. DNA damage and base excision repair in mitochondria and their role in aging. J. Aging Res. 2010, 2011, 257093.
78. Kirkinezos, I.G.; Moraes, C.T. Reactive oxygen species and mitochondrial diseases. Semin. Cell Dev. Biol. 2001, 12, 449-457.